DTL
TVRD

Dynamic Technology Lab’s Tvardi Therapeutics TVRD Stock Holding History

Dynamic Technology Lab’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-435
Closed -$26K – 1459
2023
Q3 		$26K Buy
+435
New +$40.8K ﹤0.01% 906
2023
Q2 		– Sell
-400
Closed -$71K – 1481
2023
Q1 		$71K Buy
+400
New +$134K 0.01% 991
2022
Q1 		– Sell
-1,295
Closed -$568K – 1599
2021
Q4 		$568K Buy
+1,295
New +$651K 0.06% 520
2021
Q3 		– Sell
-570
Closed -$293K – 1531
2021
Q2 		$293K Buy
+570
New +$361K 0.03% 796
2020
Q4 		– Sell
-436
Closed -$200K – 1418
2020
Q3 		$200K Buy
+436
New +$253K 0.03% 806
2017
Q4 		– Sell
-915
Closed -$451K – 1392
2017
Q3 		$451K Buy
+915
New +$458K 0.07% 489

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dynamic Technology Lab's TVRD Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Tvardi Therapeutics (TVRD) in Q4 2023, closing a stake of 435 shares — an estimated $26K sold.

Dynamic Technology Lab first reported a position in TVRD in Q3 2017 and held it in 6 quarters. The position peaked at $568K in Q4 2021. 109 funds tracked by Wall St. Rank hold TVRD as of Q4 2023.

  • Dynamic Technology Lab reported no remaining Tvardi Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 435 Tvardi Therapeutics shares in Q4 2023, an estimated $26K.
  • Dynamic Technology Lab first reported a position in Tvardi Therapeutics in Q3 2017 and held it in 6 quarters.
  • Dynamic Technology Lab's Tvardi Therapeutics position peaked at $568K in Q4 2021.
  • 109 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.